Skip to content
RDL Network logo
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial — Andrea Vanzulli (2025) | RDL Network